CD133 is expressed also by CSCs in various types of cancers including breast, ovary, prostate, colon, liver, lung, and renal cancers, glioblastoma, and medulloblastoma, but it still remains elusive on the roles of CD133 in CSC maintenance. This evidence concerns the gene PROM1 and renal carcinoma.